Group One Trading, L.P. Ardelyx, Inc. Transaction History
Group One Trading, L.P.
- $2.81 Billion
- Q3 2025
A detailed history of Group One Trading, L.P. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 93,271 shares of ARDX stock, worth $547,500. This represents 0.02% of its overall portfolio holdings.
Number of Shares
93,271
Previous 288,961
67.72%
Holding current value
$547,500
Previous $1.13 Million
54.59%
% of portfolio
0.02%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding ARDX
# of Institutions
245Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...